| Sudden sensorineural hearing loss BE Schreiber, C Agrup, DO Haskard, LM Luxon The Lancet 375 (9721), 1203-1211, 2010 | 693 | 2010 |
| Prediction of pulmonary complications and long‐term survival in systemic sclerosis SI Nihtyanova, BE Schreiber, VH Ong, D Rosenberg, P Moinzadeh, ... Arthritis & rheumatology 66 (6), 1625-1635, 2014 | 498 | 2014 |
| Live lecture versus video podcast in undergraduate medical education: A randomised controlled trial BE Schreiber, J Fukuta, F Gordon BMC medical education 10, 1-6, 2010 | 358 | 2010 |
| Borderline mean pulmonary artery pressure in patients with systemic sclerosis: transpulmonary gradient predicts risk of developing pulmonary hypertension CJ Valerio, BE Schreiber, CE Handler, CP Denton, JG Coghlan Arthritis & Rheumatism 65 (4), 1074-1084, 2013 | 218 | 2013 |
| Evidence for the involvement of type I interferon in pulmonary arterial hypertension PM George, E Oliver, P Dorfmuller, OD Dubois, DM Reed, NS Kirkby, ... Circulation research 114 (4), 677-688, 2014 | 144 | 2014 |
| Characteristics and survival of anti–U1 RNP antibody–positive patients with connective tissue disease–associated pulmonary arterial hypertension V Sobanski, J Giovannelli, BM Lynch, BE Schreiber, SI Nihtyanova, ... Arthritis & rheumatology 68 (2), 484-493, 2016 | 88 | 2016 |
| Survival in portopulmonary hypertension: outcomes of the United Kingdom national pulmonary arterial hypertension registry S Sithamparanathan, A Nair, L Thirugnanasothy, JG Coghlan, R Condliffe, ... The Journal of Heart and Lung Transplantation 36 (7), 770-779, 2017 | 78 | 2017 |
| Clinical characteristics, haemodynamics and treatment of pulmonary hypertension in sarcoidosis in a single centre, and meta-analysis of the published data D Dobarro, BE Schreiber, C Handler, H Beynon, CP Denton, JG Coghlan The American journal of cardiology 111 (2), 278-285, 2013 | 65 | 2013 |
| Perioperative management of patients with pulmonary hypertension undergoing non-cardiothoracic, non-obstetric surgery: a systematic review and expert consensus statement LC Price, G Martinez, A Brame, T Pickworth, C Samaranayake, ... British journal of anaesthesia 126 (4), 774-790, 2021 | 64 | 2021 |
| Improving the detection of pulmonary hypertension in systemic sclerosis using pulmonary function tests BE Schreiber, CJ Valerio, GJ Keir, C Handler, AU Wells, CP Denton, ... Arthritis & Rheumatism 63 (11), 3531-3539, 2011 | 60 | 2011 |
| Resolution of Behçet's syndrome associated pulmonary arterial aneurysms with infliximab BE Schreiber, N Noor, CF Juli, DO Haskard Seminars in arthritis and rheumatism 41 (3), 482-487, 2011 | 57 | 2011 |
| Clinical features and management of erythromelalgia: long term follow-up of 46 cases LK Parker, C Ponte, KJ Howell, VH Ong, CP Denton, BE Schreiber Clinical and Experimental Rheumatology 35 (1), 80-84, 2017 | 41 | 2017 |
| EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results … RA Lewis, I Armstrong, C Bergbaum, MJ Brewis, J Cannon, ... European Respiratory Journal 57 (2), 2021 | 39 | 2021 |
| The CRASH report: emergency management dilemmas facing acute physicians in patients with pulmonary arterial hypertension LC Price, K Dimopoulos, P Marino, R Alonso-Gonzalez, C McCabe, ... Thorax 72 (11), 1035-1045, 2017 | 35 | 2017 |
| Prognostic significance of computed tomography criteria for pulmonary veno-occlusive disease in systemic sclerosis-pulmonary arterial hypertension MJ Connolly, S Abdullah, DA Ridout, BE Schreiber, JA Haddock, ... Rheumatology 56 (12), 2197-2203, 2017 | 32 | 2017 |
| Pulmonary hypertension in systemic lupus erythematosus BE Schreiber, MJ Connolly, JG Coghlan Best Practice & Research Clinical Rheumatology 27 (3), 425-434, 2013 | 31 | 2013 |
| Role of N-terminal pro-brain natriuretic peptide in detecting clinically significant cardiac involvement in systemic sclerosis patients C Chighizola, PL Meroni, BE Schreiber, JG Coghlan, CP Denton, VH Ong Clinical and Experimental Rheumatology-Incl Supplements 30 (2), S81, 2012 | 30 | 2012 |
| Pulmonary arterial hypertension with abnormal V/Q single-photon emission computed tomography K Chan, S Ioannidis, JG Coghlan, M Hall, BE Schreiber JACC: Cardiovascular Imaging 11 (10), 1487-1493, 2018 | 26 | 2018 |
| Saddle-nose deformities in the rheumatology clinic. BE Schreiber, S Twigg, J Marais, A Keat ENT: Ear, Nose & Throat Journal 93, 2014 | 22 | 2014 |
| Neprilysin inhibition for pulmonary arterial hypertension: a randomized, double‐blind, placebo‐controlled, proof‐of‐concept trial AJ Hobbs, AJ Moyes, RS Baliga, D Ghedia, R Ochiel, Y Sylvestre, ... British Journal of Pharmacology 176 (9), 1251-1267, 2019 | 21 | 2019 |
Athol U WellsProfessor of Respiratory Medicine, Imperial College,在 rbht.nhs.uk 的电子邮件经过验证
